Skip to content 
Article by Christian Goergen, Founding partner at Catalpa Ventures, as published in Insight/Out magazine #37.
Introduction of Catalpa Ventures
Catalpa Ventures is the first Luxembourg‑based Venture Capital firm dedicated to investing in early‑stage HealthTech startups in Europe. Founded by a team of professionals with backgrounds in medicine, venture capital, and entrepreneurship, the firm recently celebrated its first closing with over €10 million and is on track to reach its total fund target of €30 million by 2027. Catalpa is driven by a mission to improve the health of 100 million people by addressing key challenges facing healthcare systems: an ageing society, a shortage of skilled labor, and rapidly rising costs.
Healthcare is under structural pressure
Across Europe, healthcare systems face challenges that are structural, compounding, and mutually reinforcing. In 2024, 21.6% of the EU population was aged 65 or older and the median age reached 44.7 years, reflecting a demographic shift that directly increases demand for healthcare services and long‑term support.
At the same time, healthcare delivery is constrained by workforce availability and rising costs. The WHO projects a shortage of 4.1 million healthcare professionals by 2030. These pressures are not short‑term issues that can be solved by incremental reforms alone. They influence how care is accessed, how quickly patients are treated, and how sustainably systems can operate over time.
In this environment, digital health and HealthTech are increasingly moving from “nice‑to‑have” to “mission‑critical.” They are becoming one of the most important tools to address three interconnected challenges shaping the future of healthcare.
Ageing society: closing the gap between lifespan and health span
Europe’s ageing trend is not only a story about longevity, but also about complexity. As populations age, the prevalence of chronic diseases rises, multi‑morbidity becomes more common, and care coordination becomes more demanding. This creates pressure across the system: more consultations, diagnostics, follow‑ups, and long‑term support.
A key challenge is the widening gap between lifespan and healthspan. People live longer, but often spend more years managing chronic conditions. This has major implications for both individuals and healthcare systems. The European Commission’s 2024 Ageing Report highlights population ageing as a key driver of increasing health expenditure and shows how demographic assumptions influence future spending trajectories.
HealthTech innovation increasingly targets this challenge through earlier detection, prevention, and decentralized care models that reduce reliance on hospital infrastructure and in‑person visits. Preventive approaches are particularly relevant because many healthcare systems remain reactive, focusing on treatment after symptoms appear rather than reducing risk earlier.
Shortage of healthcare professionals: scaling care without scaling headcount
The shortage of healthcare professionals has become one of the defining constraints in European healthcare. It is not only a recruitment issue but also a retention challenge. Workload, administrative burden, and burnout contribute to a system where capacity cannot expand quickly enough to match rising demand.
The situation is widely documented. A European Parliament briefing on “The Health workforce crisis in the European Union” from September 2025 notes that 20 EU countries reported shortages of physicians and 15 reported shortages of nurses. The same briefing highlights the age structure of the workforce: over one‑third of physicians and around one‑quarter of nurses in the EU are over 55, implying significant retirement pressure during the coming decade.
This context shifts the focus of innovation. HealthTech cannot and should not replace clinicians, but it can create clinical leverage by enabling professionals to care for more patients safely through improved decision support, monitoring, and workflow efficiency.
A concrete example is the first investment of the Catalpa Health Fund I, Noah Labs, which developed a telemonitoring solution for congestive heart failure using vocal biomarkers recorded through a patient’s smartphone. Congestive heart failure is the leading cause of hospitalization in Europe and represents a potential €14 billion annual cost saving opportunity. Remote, AI‑supported monitoring can help detect deterioration earlier and focus clinician attention where it is most needed.
Escalating health system costs: efficiency as a clinical priority
Cost pressure is often viewed through a fiscal lens, yet its consequences are increasingly clinical. When systems struggle to fund capacity in line with demand, delayed access, service constraints, and fragmentation become unavoidable.
European healthcare spending has almost doubled in the past decade, reaching around €1.8 trillion for EU‑27 countries in 2025, or roughly 10% of GDP. This level of spending highlights both the importance of healthcare and the scale of the challenge. Even modest efficiency improvements can translate into meaningful system‑level impact.
HealthTech can contribute to cost containment when it reduces avoidable high‑cost utilization, improves care coordination, or streamlines clinical pathways. One example is Catalpa portfolio company Remi Health, which enables remote diagnostics and screening models that shift testing from facilities to the home, reduce unnecessary in‑person visits, and support earlier intervention when appropriate.
The goal is not digitization for its own sake but measurable efficiency: fewer avoidable admissions, earlier detection, improved adherence, and reduced administrative burden.
Why “now” looks different: technology maturity meets system necessity
The challenges of ageing populations, workforce shortages, and rising costs are not new. What has changed is the feasibility of addressing them at scale. Artificial intelligence capabilities, smartphone‑based diagnostics, and remote monitoring tools have matured significantly, while hybrid care models have become more accepted by both patients and providers.
Investment activity also reflects this shift. European HealthTech companies continue to attract significant funding, suggesting that investors increasingly believe scalable digital solutions can deliver both clinical and economic value.
Luxembourg’s role: small country, high leverage
Luxembourg has an opportunity to contribute meaningfully to Europe’s healthcare transformation by strengthening the connections between innovators and healthcare systems through validation pathways, partnerships, and implementation capacity.
A notable recent development is the creation of HIVE (www.hive-services.lu), which aims to strengthen ecosystem infrastructure and foster collaboration between innovators and healthcare stakeholders. With more than 100 members including hospitals, research organizations, startups, and venture investors, the network is growing quickly and demonstrates the value of close collaboration.
Why European HealthTech is emerging as a high‑quality VC category
From a venture and private markets perspective, health‑related innovation increasingly shows characteristics associated with resilient investment categories: durable demand, large addressable markets, and multiple exit pathways.
Healthcare demand is fundamentally non‑discretionary. Patients require diagnosis, treatment, and long‑term management regardless of consumer sentiment or corporate IT budgets. In a market where many technology sectors are exposed to cyclical spending cuts, HealthTech benefits from structural drivers such as ageing populations and the growing prevalence of chronic disease.
This resilience is particularly relevant in today’s volatile environment. Europe continues to navigate uncertainty from inflation, interest rate sensitivity, geopolitical disruptions, and political instability in global markets. In such periods, healthcare systems do not pause. If anything, pressure around workforce capacity and cost containment intensifies.
European HealthTech also offers diversification in commercialization and exit routes. Innovation can scale through providers, payers, patients, pharmaceutical companies, medtech firms, and even employers. On the exit side, the market benefits from active strategic acquirers and growing private equity interest in scalable healthcare software and services.
Three interconnected challenges, one unique opportunity
Ageing societies, shortages of healthcare professionals, and escalating system costs are converging into a single mandate for change. HealthTech can help address these pressures through remote diagnostics, AI‑supported monitoring, workflow automation, and hybrid care models. Lasting impact, however, will depend on ecosystem infrastructure and clear implementation pathways that enable adoption at scale.
From an investment perspective, European HealthTech combines durable demand with large markets and multiple exit opportunities, making it a resilient category even in volatile times. As political and macroeconomic uncertainty persists, solutions that increase productivity and efficiency in care delivery remain strategically relevant, because healthcare demand does not pause.
